HopeStage
Back to all studies
RecruitingNCT06914284

Apathy-related Neurobehavioral Markers of Cognitive Decline in Old-age Bipolarity: Proof-of-concept

A short description of this study’s research objective has not yet been verified.

Observational studyAges 70–85France
The study in practice

Understand this study

Who could participate?

Listed age limits: 70 years to 85 years.

Listed locations
Rennes, FranceSee all locations and recruitment
Compensation
Payment and expense reimbursement have not been verified.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: July 1, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
30
Sponsor
Hospital Center Guillaume Régnier
Sponsor type
Hospital / academic medical center
Study type
Observational
Intervention type
OTHER
Study phase
Not clearly listed
Locations
France
Age range
From 70 Years to 85 Years
Official registry ID
NCT06914284
Official title
Apathy-related Neurobehavioral Markers of Cognitive Decline in Old-age Bipolar Disorders: Proof-of-concept

Want help reviewing this study?

Loading the security check...
Study ID: NCT06914284. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Recruiting

Rennes

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Hospital Center Guillaume Régnier, a hospital or academic medical center.

Who can participate?

Listed age limits: 70 years to 85 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me